Cedars-Sinai launches Alexa pilot in 100 patient rooms

Cedars-Sinai, a non-profit hospital based in California, is launching a pilot program to outfit 100 patient rooms with a platform powered by Amazon’s voice technology, Alexa. The platform, known as Aiva, will enable patients to request some tasks to be performed by the voice assistant, such as turning on the television, changing the channel and making requests to nurses.

The pilot reflects the rising use of voice technology across industries. Patients in hospitals most frequently request voice technology to make environmental controls, such as playing music.

The platform could free up nurses to be more focused on delivering patient care. Patient requests are routed to an appropriate caregiver’s mobile phone. For example, a patient’s requests for help using the bathroom would be routed to a clinical partner, and a pain medicine request would reach a registered nurse.

“Whereas previously nurses were frequently asked to help with the in-room television, Alexa does that job for us, allowing nurses to focus on providing the highest level of patient care," Golda Morales, assistant nurse manager of general surgery at Cedars-Sinai, said in a statement.

If requests aren’t answered quickly, the platform sends it up the chain of command, according to the announcement.

Cedars-Sinai has made other investments to bring its hospital rooms into the 21st century, including using the MyChart Bedside app and an iPad project that modernizes patient communication.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.